Navigation Links
ROX Medical enrolls first UK patients in CONTROL-HTN hypertension trial at Eastbourne General Hospital
Date:3/18/2013

SAN CLEMENTE, Calif., March 18, 2013 /PRNewswire/ -- ROX Medical announced enrollment of the first UK patients in the CONTROL-HTN international randomized controlled trial of the ROX FLOW procedure for the treatment of resistant hypertension (high blood pressure). The first patients were enrolled at Eastbourne General Hospital, East Sussex, UK by Doctors Neil Sulke and Stephan Furniss . For the two patients randomized to treatment, the ROX procedure was performed in the Cardiac Catheter Lab in under one hour: "It was a very enjoyable and straightforward procedure on a patient with very difficult to control blood pressure," commented Dr. Furniss. "The procedure was relatively painless and the patient showed significant improvement in blood pressure right after the procedure that we'll be anxious to monitor over the coming weeks and months." "We like the fact that the ROX procedure is reversible and that it can treat patients who are not candidates or don't seem to respond to renal denervation," added Dr. Sulke. "This could be a very important new device treatment option for resistant hypertension patients," said Dr. Furniss. "We are anxious to enroll additional patients into this exciting trial."

ROX Medical's FLOW procedure is a minimally invasive, catheter procedure to place a small coupler between the artery and vein in the upper leg. The procedure reduces peripheral vascular resistance and by diverting some arterial blood to the veins, adds lost compliance back into the vascular system. Uniquely, the FLOW procedure only involves vascular structures away from vital organs like the kidneys, has an immediate effect and is fully reversible. The procedure also doesn't require heavy pain medications common to renal ablation techniques. The ROX procedure holds the promise of a meaningful long-term reduction in hypertension that may be combined with other device hypertension therapies.

"We are honored and excited to have the highly respected team of cardiologists at Eastbourne involved in the CONTROL-HTN study," said ROX CEO Rodney Brenneman .

The ROX FLOW procedure for hypertension is not approved for use in the U.S.


'/>"/>
SOURCE ROX Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lung Cancer Alliance Congratulates 75 Medical Centers For Moving Swiftly And Responsibly On Lung Cancer Screening
2. Medical Device Developers - Network at BIOMEDevice Boston Next Week
3. Winner Medicals Special Committee Appoints Independent Financial Advisor and Retains Legal Counsel
4. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
5. CareFusion to Sell Neurodiagnostic Business to Natus Medical for $58 Million
6. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Essential Medical Dismisses Patent Case against Masimo and Cercacor
9. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
10. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
11. Enox Biopharma, Inc. To Present Today At IN3 Medical Device 360 Conference In London
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)...  Endo International plc (NASDAQ: ENDP ) ... its manufacturing network, the Company will be ceasing operations ... Huntsville, Alabama . The closure of the ... 12 to 18 months. The Huntsville ... commoditized products and these restructuring actions are intended to ...
(Date:7/17/2017)...  MedX Holdings, Inc., the manufacturer and global distributor ... equipment, today announced the national roll out of its ... gold standard for the treatment of low back injuries ... How it works: ... practice who prescribe the MedX Home Back Machine Program ...
(Date:7/13/2017)... , July 13, 2017  Centurion Medical Products, a leader ... DisImpactor ® fecal impaction removal device for hospice patient care. ... Centurion ... Patient pain management and emotional ... Hospice can help alleviate patient pain while preventing unneeded emergency department ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... , ... A CDC study shows that, although people are taking more steps to protect themselves ... at least one case of sunburn within the past year. It’s common and people have ... issue. However, only recently have people become conscientious of the risks that accompany sunburns. , ...
(Date:7/24/2017)... Switzerland (PRWEB) , ... July 24, 2017 , ... Anyone ... to weigh a watermelon, nor would a pharmacist using that same scale to dispense ... risk someone’s health. , These illustrations show why it is important to have ...
(Date:7/24/2017)... ... July 24, 2017 , ... Sharon Kleyne, host of ... Your Health on VoiceAmerica sponsored by Nature’s Tears® EyeMist® recently talked on the air ... myopia in China. , The article by Zidor Aldama described the situation in which ...
(Date:7/24/2017)... Houston, TX (PRWEB) , ... July 24, 2017 , ... ... group of the nation’s top level plastic surgeons, invited to attend Allergan’s recent meeting ... top 10 most valued companies in the world, Allergan is bringing a newly defined ...
(Date:7/24/2017)... ... July 24, 2017 , ... The ... StorErotica “Consumer’s Choice” Award, for favorite sex toy. Created in collaboration with website ... Awards to be consumer voted. The Magic Wand Rechargeable won in stiff competition ...
Breaking Medicine News(10 mins):